Brain Meningioma, also known as intracranial meningioma, is related to benign meningioma and meningioma, familial, and has symptoms including headache and seizures. An important gene associated with Brain Meningioma is NF2 (NF2, Moesin-Ezrin-Radixin Like (MERLIN) Tumor Suppressor), and among its related pathways/superpathways are RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known and Tumor suppressor activity of SMARCB1. The drugs Temsirolimus and Sirolimus have been mentioned in the context of this disorder. Affiliated tissues include Brain and spinal cord, and related phenotype is Increased proliferation.